Significant reduction of vascular risk factors after two years of follow-up in the population-based intervention project INVADE;Signifikante reduktion vaskulärer risikofaktoren im rahmen des populationsbasierten interventions-projektes INVADE - Eine 2-jahres- verlaufsuntersuchung

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 34-35, 2006, Pages 1853-1859

  Sander, Kerstin ^a,c   Horn, C Schulze ^a   Briesenick, C ^b   Sander, D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INVADE Study Group

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Epidemiology; Intervention; Prevention; Risk factors; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT;

AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; STROKE; SYSTOLIC BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; GERMANY; INCIDENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SEX DIFFERENCE;

AGED; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; DEMENTIA; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INCIDENCE; LIFE STYLE; MALE; RISK FACTORS; SEX FACTORS;

EID: 33749161867     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-949168     Document Type: Article

References (26)

1. European Society of Hypertension-European Society of Cardiology Guidelines Committee. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053
2. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001; 357: 995-1001
3. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29(Suppl 1): S43-48
4. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554-572
5. Assmann C, Cullen P, Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998(Suppl A19: A2-11
6. Baigent C, Keech A, Kearney PM et al. Efficacy and safety of cholesterol-lowering treatment. Lancet 2005; 366: 1267-1278
7. Burger M, Tiemann F. Diabetes mellitus in Deutschland. Eine Bestandsaufnahme nach Daten des telefonischen Gesundheitssurveys 2003. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005; 48: 1242-1249
8. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Jama 2003; 289: 2560-2572
9. Gasse C, Hense HW, Stieber J et al. Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995. J Hum Hypertens 2001; 15: 27-36
10. Gil-Nunez AC, Vivancos-Mora J. Blood pressure as a risk factor for stroke and the impact of antihypertensive treatment. Cerebrovasc Dis 2005(Suppl 220: 40-52
11. Grundy SM, Cleeman JI, Merz CM et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-239
12. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999; 354: 1457-1463
13. Heinemann LA, Barth W, Garbe L, Willich SN, Kunze K. Epidemiologische Daten zur Schlaganfallerkrankung. Daten des WHO-MONICA-Projekts in Deutschland. Nervenarzt 1998; 69: 1091-1099
14. Kjeldsen SE, Julius S, Hedner T, Hansson L. Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials. Blood Press 2001; 10: 190-192
15. Kolominsky-Rabas PL, Heuschmann PU, Marschall D et al. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke 2006; 37: 1179-1183
16. Launer LJ, Andersen K, Dewey ME et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999; 52: 78-84
17. Murphy NF, MacIntyre K, Stewart S et al. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women. Eur Heart J 2006; 27: 96-106
18. Rexrode KM, Hennekens WH, Willett WC et al. A prospective study of body mass index, weight change, and risk of stroke in women. Jama 1997; 277: 1539-1545
19. Rothwell PM. Prevention of stroke in patients with diabetes mellitus and the metabolic syndrome. Cerebrovasc Dis 2005(Suppl 120: 24-34
20. Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B. Combined Effects of Hemoglobin A1c and C-Reactive Protein on the Progression of Subclinical Carotid Atherosclerosis: The INVADE Study. Stroke 2006;37:351-357
21. Scherpinski U, Bickel H, Gnahn H, Forstl H, Conrad B, Sander D. Interventionsprojekt zu zerebrovaskulären Erkrankungen und Demenz im Landkreis Ebersberg (INVADE): Rationale und Projektdesign. Nervenarzt 2002; 73: 1199-1204
22. Sharma AM, Wittchen HU, Kirch Wet al. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 2004; 22: 479-86
23. Suk SH, Sacco RL, Boden-Albala B et al. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2003; 34: 1586-1592
24. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053
25. Wolf-Maier K, Cooper RS, Banegas JR et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. Jama 2003; 289: 2363-2369
26. York DA, Rossner S, Caterson I et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group I: worldwide demographics of obesity. Circulation 2004; 110: 463-470